125 related articles for article (PubMed ID: 31539535)
1. Estrogen signaling and estrogen receptors as prognostic indicators in laryngeal cancer.
Verma A; Schwartz N; Cohen DJ; Boyan BD; Schwartz Z
Steroids; 2019 Dec; 152():108498. PubMed ID: 31539535
[TBL] [Abstract][Full Text] [Related]
2. Loss of Estrogen Receptors is Associated with Increased Tumor Aggression in Laryngeal Squamous Cell Carcinoma.
Verma A; Schwartz N; Cohen DJ; Patel V; Nageris B; Bachar G; Boyan BD; Schwartz Z
Sci Rep; 2020 Mar; 10(1):4227. PubMed ID: 32144339
[TBL] [Abstract][Full Text] [Related]
3. Sex-related hormone receptor in laryngeal squamous cell carcinoma: correlation with androgen estrogen-ɑ and prolactin receptor expression and influence of prognosis.
Fei M; Zhang J; Zhou J; Xu Y; Wang J
Acta Otolaryngol; 2018 Jan; 138(1):66-72. PubMed ID: 28889782
[TBL] [Abstract][Full Text] [Related]
4. 17Beta-estradiol promotes aggressive laryngeal cancer through membrane-associated estrogen receptor-alpha 36.
Schwartz N; Chaudhri RA; Hadadi A; Schwartz Z; Boyan BD
Horm Cancer; 2014 Feb; 5(1):22-32. PubMed ID: 24081562
[TBL] [Abstract][Full Text] [Related]
5. Role of ERα36 in membrane-associated signaling by estrogen.
Chaudhri RA; Schwartz N; Elbaradie K; Schwartz Z; Boyan BD
Steroids; 2014 Mar; 81():74-80. PubMed ID: 24252378
[TBL] [Abstract][Full Text] [Related]
6. Estradiol receptor profile and estrogen responsiveness in laryngeal cancer and clinical outcomes.
Schwartz N; Verma A; Muktipaty C; Bivens C; Schwartz Z; Boyan BD
Steroids; 2019 Feb; 142():34-42. PubMed ID: 29274403
[TBL] [Abstract][Full Text] [Related]
7. MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer.
Lettlova S; Brynychova V; Blecha J; Vrana D; Vondrusova M; Soucek P; Truksa J
Cell Physiol Biochem; 2018; 46(6):2601-2615. PubMed ID: 29763890
[TBL] [Abstract][Full Text] [Related]
8. From ERα66 to ERα36: a generic method for validating a prognosis marker of breast tumor progression.
Chamard-Jovenin C; Jung AC; Chesnel A; Abecassis J; Flament S; Ledrappier S; Macabre C; Boukhobza T; Dumond H
BMC Syst Biol; 2015 Jun; 9():28. PubMed ID: 26080803
[TBL] [Abstract][Full Text] [Related]
9. ERRF is essential for Estrogen-Estrogen Receptor alpha signaling pathway in ER positive breast cancer cells.
Luo A; Zhang X
Biochem Biophys Res Commun; 2016 May; 474(2):400-405. PubMed ID: 27125460
[TBL] [Abstract][Full Text] [Related]
10. [The expression and clinical progression of androgen, estrogen and prolactin receptor in laryngeal squamous cell carcinoma].
Fei MJ; Xu YN; Wang JD
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 32(3):190-195. PubMed ID: 29775019
[No Abstract] [Full Text] [Related]
11. [Estrogen receptor expression in tumors different from breast cancer].
Bogush TA; Dudko EA; Beme AA; Bogush EA; Polotskiĭ BE; Tiuliandin SA; Davydov MI
Antibiot Khimioter; 2009; 54(7-8):41-9. PubMed ID: 20201403
[TBL] [Abstract][Full Text] [Related]
12. ERα36-GPER1 Collaboration Inhibits TLR4/NFκB-Induced Pro-Inflammatory Activity in Breast Cancer Cells.
Notas G; Panagiotopoulos A; Vamvoukaki R; Kalyvianaki K; Kiagiadaki F; Deli A; Kampa M; Castanas E
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299224
[TBL] [Abstract][Full Text] [Related]
13. Expression and localization of estrogen receptor in human breast cancer and its clinical significance.
Li L; Wang Q; Lv X; Sha L; Qin H; Wang L; Li L
Cell Biochem Biophys; 2015 Jan; 71(1):63-8. PubMed ID: 25113640
[TBL] [Abstract][Full Text] [Related]
14. AKT alters genome-wide estrogen receptor alpha binding and impacts estrogen signaling in breast cancer.
Bhat-Nakshatri P; Wang G; Appaiah H; Luktuke N; Carroll JS; Geistlinger TR; Brown M; Badve S; Liu Y; Nakshatri H
Mol Cell Biol; 2008 Dec; 28(24):7487-503. PubMed ID: 18838536
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptors: role in breast cancer.
Duffy MJ
Crit Rev Clin Lab Sci; 2006; 43(4):325-47. PubMed ID: 16769596
[TBL] [Abstract][Full Text] [Related]
16. ERE-independent ERalpha target genes differentially expressed in human breast tumors.
Glidewell-Kenney C; Weiss J; Lee EJ; Pillai S; Ishikawa T; Ariazi EA; Jameson JL
Mol Cell Endocrinol; 2005 Dec; 245(1-2):53-9. PubMed ID: 16298037
[TBL] [Abstract][Full Text] [Related]
17. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
[TBL] [Abstract][Full Text] [Related]
18. KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function.
Gala K; Li Q; Sinha A; Razavi P; Dorso M; Sanchez-Vega F; Chung YR; Hendrickson R; Hsieh JJ; Berger M; Schultz N; Pastore A; Abdel-Wahab O; Chandarlapaty S
Oncogene; 2018 Aug; 37(34):4692-4710. PubMed ID: 29755131
[TBL] [Abstract][Full Text] [Related]
19. Estrogens promote proliferation of the seminoma-like TCam-2 cell line through a GPER-dependent ERα36 induction.
Wallacides A; Chesnel A; Ajj H; Chillet M; Flament S; Dumond H
Mol Cell Endocrinol; 2012 Mar; 350(1):61-71. PubMed ID: 22138413
[TBL] [Abstract][Full Text] [Related]
20. Activation of ClC-3 chloride channel by 17β-estradiol relies on the estrogen receptor α expression in breast cancer.
Yang H; Ma L; Wang Y; Zuo W; Li B; Yang Y; Chen Y; Chen L; Wang L; Zhu L
J Cell Physiol; 2018 Feb; 233(2):1071-1081. PubMed ID: 28419445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
